germline brca2 mutational Search Results


90
MultiCASE Inc mutations in brca1 and brca2
Three-generation family, ascertained through a proband with breast cancer at age <40 years, showing age at onset, death, or interview, that gives most support for a recessively inherited risk of breast cancer. The proband has not been found to carry a germline mutation in either BRCA1 or <t>BRCA2.</t>
Mutations In Brca1 And Brca2, supplied by MultiCASE Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/germline+brca2+mutational/pmc01235275-381-7-18?v=MultiCASE+Inc
Average 90 stars, based on 1 article reviews
mutations in brca1 and brca2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Hamamatsu germline mutations of brca2
Three-generation family, ascertained through a proband with breast cancer at age <40 years, showing age at onset, death, or interview, that gives most support for a recessively inherited risk of breast cancer. The proband has not been found to carry a germline mutation in either BRCA1 or <t>BRCA2.</t>
Germline Mutations Of Brca2, supplied by Hamamatsu, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/germline+brca2+mutational/2R2829lM0ivDgITVEhiTw2bY2kSAhyCOR7bWHjSiSbN6TBA7ysupsBcBjuB37A6zBLXeg3YZz5glS1F8r-1-80-74?v=Hamamatsu
Average 90 stars, based on 1 article reviews
germline mutations of brca2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Future Medicine Ltd germline mutation in brca2
Three-generation family, ascertained through a proband with breast cancer at age <40 years, showing age at onset, death, or interview, that gives most support for a recessively inherited risk of breast cancer. The proband has not been found to carry a germline mutation in either BRCA1 or <t>BRCA2.</t>
Germline Mutation In Brca2, supplied by Future Medicine Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/germline+brca2+mutational/pm32249603-28-6-28?v=Future+Medicine+Ltd
Average 90 stars, based on 1 article reviews
germline mutation in brca2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Three-generation family, ascertained through a proband with breast cancer at age <40 years, showing age at onset, death, or interview, that gives most support for a recessively inherited risk of breast cancer. The proband has not been found to carry a germline mutation in either BRCA1 or BRCA2.

Journal:

Article Title: After BRCA1 and BRCA2--What Next? Multifactorial Segregation Analyses of Three-Generation, Population-Based Australian Families Affected by Female Breast Cancer

doi:

Figure Lengend Snippet: Three-generation family, ascertained through a proband with breast cancer at age <40 years, showing age at onset, death, or interview, that gives most support for a recessively inherited risk of breast cancer. The proband has not been found to carry a germline mutation in either BRCA1 or BRCA2.

Article Snippet: The penetrances of mutations in BRCA1 and BRCA2 were assumed to be that estimated from previous analyses of multicase families.

Techniques: Mutagenesis

Segregation Analysis of Single-Locus Models, Based on 824 Families with Known BRCA1 and  BRCA2  Mutation Carriers and Their Relatives Excluded

Journal:

Article Title: After BRCA1 and BRCA2--What Next? Multifactorial Segregation Analyses of Three-Generation, Population-Based Australian Families Affected by Female Breast Cancer

doi:

Figure Lengend Snippet: Segregation Analysis of Single-Locus Models, Based on 824 Families with Known BRCA1 and BRCA2 Mutation Carriers and Their Relatives Excluded

Article Snippet: The penetrances of mutations in BRCA1 and BRCA2 were assumed to be that estimated from previous analyses of multicase families.

Techniques: Mutagenesis

Segregation Analyses of Two-Locus Models, Assuming the Interaction Effect is Multiplicative or Additive, Based on All 858 Families and on the 824 Families with Known BRCA1 and  BRCA2  Mutation Carriers and Their Relatives Excluded

Journal:

Article Title: After BRCA1 and BRCA2--What Next? Multifactorial Segregation Analyses of Three-Generation, Population-Based Australian Families Affected by Female Breast Cancer

doi:

Figure Lengend Snippet: Segregation Analyses of Two-Locus Models, Assuming the Interaction Effect is Multiplicative or Additive, Based on All 858 Families and on the 824 Families with Known BRCA1 and BRCA2 Mutation Carriers and Their Relatives Excluded

Article Snippet: The penetrances of mutations in BRCA1 and BRCA2 were assumed to be that estimated from previous analyses of multicase families.

Techniques: Mutagenesis

Age-specific cumulative probabilities of breast cancer for the population, for carriers of a dominantly inherited and a recessively inherited risk, and for noncarriers of the recessively inherited risk, with 95% CIs, on the basis of the 824 families with known BRCA1 and BRCA2 mutation carriers and their relatives excluded, under the multiplicative two-locus model.

Journal:

Article Title: After BRCA1 and BRCA2--What Next? Multifactorial Segregation Analyses of Three-Generation, Population-Based Australian Families Affected by Female Breast Cancer

doi:

Figure Lengend Snippet: Age-specific cumulative probabilities of breast cancer for the population, for carriers of a dominantly inherited and a recessively inherited risk, and for noncarriers of the recessively inherited risk, with 95% CIs, on the basis of the 824 families with known BRCA1 and BRCA2 mutation carriers and their relatives excluded, under the multiplicative two-locus model.

Article Snippet: The penetrances of mutations in BRCA1 and BRCA2 were assumed to be that estimated from previous analyses of multicase families.

Techniques: Mutagenesis

Segregation Analyses of Hypergeometric Polygenic Model, with and without a Single-Locus Effect, Based on All 858 Families and on 824 Families with Known BRCA1 and  BRCA2  Mutation Carriers and Their Relatives Excluded

Journal:

Article Title: After BRCA1 and BRCA2--What Next? Multifactorial Segregation Analyses of Three-Generation, Population-Based Australian Families Affected by Female Breast Cancer

doi:

Figure Lengend Snippet: Segregation Analyses of Hypergeometric Polygenic Model, with and without a Single-Locus Effect, Based on All 858 Families and on 824 Families with Known BRCA1 and BRCA2 Mutation Carriers and Their Relatives Excluded

Article Snippet: The penetrances of mutations in BRCA1 and BRCA2 were assumed to be that estimated from previous analyses of multicase families.

Techniques: Mutagenesis